Eric-Paul Paques

Title: The Innovative Contributions of Eric-Paul Paques

Introduction

Eric-Paul Paques is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of hormonal contraception, holding a total of 2 patents. His work focuses on developing dosage forms that enhance the effectiveness and safety of hormonal contraceptives.

Latest Patents

One of his latest patents is a dosage form for hormonal contraception that contains a specific number of hormone-containing daily units and hormone-free daily units for daily, oral administration. This innovative formulation ensures that the hormone-containing daily units each contain at most the minimum effective daily amount of folic acid for women, while the hormone-free daily units contain at least a multiple of this amount up to the maximum permissible amount of folic acid for women. Another patent involves a dosage form that includes a specific number of gestagen-containing daily units A and B for uninterrupted, daily, oral administration. In this formulation, daily units A contain at most 200 µg of folic acid, while daily units B contain more than 200 µg up to the maximum permissible amount of folic acid for women.

Career Highlights

Throughout his career, Eric-Paul Paques has worked with prominent companies in the pharmaceutical industry, including Grünenthal GmbH and Richter Gedeon Nyrt. His expertise in hormonal contraception has positioned him as a valuable contributor to advancements in this area.

Collaborations

Eric-Paul has collaborated with various professionals in his field, including his coworker Georg Schramm. Their combined efforts have led to innovative solutions in hormonal contraceptive formulations.

Conclusion

Eric-Paul Paques is a distinguished inventor whose work in hormonal contraception has resulted in valuable patents that contribute to women's health. His innovative approaches continue to influence the pharmaceutical industry positively.